Table 4. Univariate and multivariate analysis of risk factors associated with mortality.
Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|
Category | n | Mortality n (%) | OR (95% CI) | p value | OR (95% CI) | p value | |
Gender | Male | 171 | 23 (13.5) | ||||
Female | 90 | 15 (16.7) | 1.287 (0.634–2.611) | 0.484 | |||
Age, years | < 63 | 137 | 4 (2.9) | ||||
> 63 | 124 | 34 (27.4) | 12.561 (4.309–36.62) | <0.001 | 1.142 (1.089–1.197) | <0.001 | |
Hypertension | Yes | 131 | 27 (20.6) | ||||
No | 130 | 11 (8.5) | 2.809 (1.328–5.939) | 0.005 | |||
Cardiovascular disease | Yes | 39 | 14 (35.9) | ||||
No | 222 | 24 (10.8) | 4.620 (2.119–10.073) | <0.001 | |||
Chronic respiratory disease | Yes | 46 | 13 (28.3) | ||||
No | 215 | 25 (11.6) | 2.994 (1.393–6.436) | 0.004 | |||
Solid Organ Transplantation | Yes | 41 | 5 (12.2) | ||||
No | 220 | 33 (15) | 0.787 (0.288–2.152) | 0.640 | |||
serum C-reactive protein (mg/dL) Day 0 | < 8.2 | 130 | 15 (11.5) | ||||
>8.2 | 131 | 23 (17.6) | 1.633 (0.810–3.293) | 0.168 | |||
serum C-reactive protein (mg/dL), maximum value | < 15.2 | 130 | 8 (6.2) | ||||
>15.2 | 131 | 30 (23) | 4.530 (1.989–10.318) | <0.001 | 3.068 (1.22–7.71) | 0.017 | |
serum Creatinine (mg/dL) Day 0 | < 0.9 | 121 | 10 (8.3) | ||||
> 0.9 | 140 | 28 (20) | 2.775 (1.287–5.983) | 0.007 | 3.048 (1.226–7.575) | 0.016 | |
Lymphocytes (cell/mm3) Day 0 | < 700 | 133 | 24 (18) | ||||
>700 | 128 | 14 (36.8) | 0.558 (0.274–1.134) | 0.104 | |||
Serum ferritin (ng/mL) Day 0 | < 749 | 124 | 14 (11.3) | ||||
>749 | 137 | 24 (17.5) | 1.669 (0.821–3.393) | 0.154 | |||
D-dimer (ng/mL) Day 0 | < 800 | 140 | 13 (9.3) | ||||
> 800 | 121 | 25 (20.7) | 2.544 (1.237–5.230) | 0.009 | |||
Intensive care unit (ICU) admission | Yes | 101 | 21 (20.8) | ||||
No | 160 | 17 (10.6) | 2.208 (1.101–4.427) | 0.023 | |||
Invasive mechanical ventilation | Yes | 53 | 12 (22.6) | ||||
No | 208 | 26 (12.5) | 2.049 (0.955–4.395) | 0.062 | |||
Septic shock | Yes | 56 | 14 (25) | ||||
No | 203 | 23 (11.3) | 2.609 (1.239–5.492) | 0.010 | |||
Biological therapy | Yes | 148 | 18 (47.4) | ||||
No | 113 | 130 (58.3) | 0.644 (0.323–1.284) | 0.209 | |||
OSDa, baseline | |||||||
Conventional ward, not requiring supplemental oxygen | Yes | 88 | 5 (5.7) | ||||
Conventional ward, requiring supplemental low-flow oxygen | Yes | 148 | 25 (16.9) | ||||
ICUb, requiring supplemental high-flow supplemental oxygen | Yes | 3 | 2 (66.7) | ||||
ICU, requiring invasive mechanical ventilation/ECMOc | Yes | 22 | 6 (27.3) | 15.629 | 0.001 |
aOSD, ordinary scale determination;
bICU, intensive care unit.
cECMO, Extracorporeal membrane oxygenation.